Jennison Associates LLC decreased its position in Monsanto Company (NYSE:MON) by 52.8% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 139,705 shares of the basic materials company’s stock after selling 156,500 shares during the period. Jennison Associates LLC’s holdings in Monsanto were worth $16,535,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also bought and sold shares of the company. BlackRock Inc. raised its position in Monsanto by 2,390.1% in the first quarter. BlackRock Inc. now owns 26,192,816 shares of the basic materials company’s stock worth $2,965,029,000 after buying an additional 25,140,936 shares during the last quarter. State Street Corp raised its position in Monsanto by 1.2% in the first quarter. State Street Corp now owns 20,153,966 shares of the basic materials company’s stock worth $2,281,433,000 after buying an additional 234,582 shares during the last quarter. Massachusetts Financial Services Co. MA raised its position in Monsanto by 3.6% in the first quarter. Massachusetts Financial Services Co. MA now owns 14,299,502 shares of the basic materials company’s stock worth $1,618,703,000 after buying an additional 499,639 shares during the last quarter. Flossbach Von Storch AG raised its position in Monsanto by 7.5% in the second quarter. Flossbach Von Storch AG now owns 4,397,000 shares of the basic materials company’s stock worth $520,429,000 after buying an additional 307,600 shares during the last quarter. Finally, Geode Capital Management LLC raised its position in Monsanto by 7.7% in the first quarter. Geode Capital Management LLC now owns 4,125,879 shares of the basic materials company’s stock worth $466,359,000 after buying an additional 295,452 shares during the last quarter. 74.79% of the stock is currently owned by institutional investors and hedge funds.

Shares of Monsanto Company (NYSE MON) opened at 117.21 on Friday. Monsanto Company has a 52-week low of $97.35 and a 52-week high of $118.97. The company has a market capitalization of $51.49 billion, a P/E ratio of 25.32 and a beta of 1.07. The stock’s 50 day moving average price is $117.18 and its 200-day moving average price is $115.99.

Monsanto (NYSE:MON) last announced its quarterly earnings results on Wednesday, June 28th. The basic materials company reported $1.93 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.74 by $0.19. The company had revenue of $4.23 billion during the quarter, compared to analysts’ expectations of $4.18 billion. Monsanto had a return on equity of 45.26% and a net margin of 14.11%. The firm’s quarterly revenue was up 1.0% compared to the same quarter last year. During the same period in the previous year, the business earned $2.17 earnings per share. On average, equities analysts expect that Monsanto Company will post $4.89 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Friday, October 6th will be given a $0.54 dividend. This represents a $2.16 annualized dividend and a dividend yield of 1.84%. The ex-dividend date of this dividend is Thursday, October 5th. Monsanto’s dividend payout ratio (DPR) is presently 46.75%.

ILLEGAL ACTIVITY NOTICE: This story was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this story on another website, it was copied illegally and reposted in violation of United States & international trademark and copyright legislation. The original version of this story can be accessed at https://www.thecerbatgem.com/2017/09/03/monsanto-company-mon-stake-lowered-by-jennison-associates-llc.html.

MON has been the topic of a number of recent analyst reports. Zacks Investment Research raised Monsanto from a “hold” rating to a “buy” rating and set a $132.00 target price on the stock in a report on Friday, June 16th. Vetr raised Monsanto from a “hold” rating to a “buy” rating and set a $122.35 target price on the stock in a report on Thursday, July 6th. UBS AG lowered Monsanto from a “buy” rating to a “neutral” rating and set a $128.00 target price on the stock. in a report on Friday, August 18th. BidaskClub raised Monsanto from a “sell” rating to a “hold” rating in a report on Saturday, August 19th. Finally, Royal Bank Of Canada reissued a “sector perform” rating and set a $128.00 target price (up from $120.00) on shares of Monsanto in a report on Thursday, June 29th. One investment analyst has rated the stock with a sell rating, twelve have given a hold rating and eight have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average target price of $123.43.

In other news, EVP Steven Mizell sold 11,300 shares of Monsanto stock in a transaction on Monday, July 3rd. The stock was sold at an average price of $118.57, for a total value of $1,339,841.00. Following the completion of the transaction, the executive vice president now directly owns 55,011 shares in the company, valued at $6,522,654.27. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, SVP Janet M. Holloway sold 7,423 shares of Monsanto stock in a transaction on Tuesday, June 13th. The shares were sold at an average price of $118.00, for a total value of $875,914.00. Following the completion of the transaction, the senior vice president now owns 33,645 shares of the company’s stock, valued at $3,970,110. The disclosure for this sale can be found here. Over the last quarter, insiders sold 71,133 shares of company stock valued at $8,397,515. 0.79% of the stock is owned by company insiders.

Monsanto Company Profile

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Institutional Ownership by Quarter for Monsanto (NYSE:MON)

Receive News & Stock Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related stocks with our FREE daily email newsletter.